Evidence of clozapine's effectiveness in schizophrenia: A systematic review and meta-analysis of randomized trials

American Journal of Psychiatry

Volumn 156, Issue 7, 1999, Pages 990-999

  Wahlbeck, Kristian ^a,b   Cheine, Maxim ^a   Essali, Adib ^a   Adams, Clive ^a  

^a Cochrane Schizophrenia Group ^*  (United Kingdom)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLOPENTHIXOL; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; THIORIDAZINE; TRIFLUOPERAZINE;

ADOLESCENT; ADULT; AGED; BLOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FEVER; HUMAN; HYPERSALIVATION; HYPOTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REVIEW; SCHIZOPHRENIA; SEDATION; SEIZURE; SIDE EFFECT; WEIGHT GAIN; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; CHILD; CLOZAPINE; HUMANS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 0033008580     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Mulrow CD: Rationale for systematic reviews. BMJ 1994; 309: 597-599
2. Oxman AD, Guyatt GH: The science of reviewing research. Ann NY Acad Sci 1993; 703:125-133
3. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR: Publication bias in clinical research. Lancet 1991; 337:867-872
4. Moher D, Fortin P, Jadad AR, Juni P, Klassen T, Le Lorier J, Liberati A, Linde K, Penna A: Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet 1996; 347:363-366
5. Schulz KF, Chalmers I, Hayes RJ, Altman DG: Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273:408-412
6. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers A: Meta-analyses of randomized controlled trials. N Engl J Med 1987; 316:450-455
7. Kane J, Honigfeld G, Singer J, Meltzer H, Clozaril Collaborative Study Group: Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45:789-796
8. Essock SM, Hargreaves WA, Dohm FA, Goethe J, Carver L, Hipshman L: Clozapine eligibility among state hospital patients. Schizophr Bull 1996; 22:15-25
9. Essock SM, Hargreaves WA, Covell NH, Goethe J: Clozapine's effectiveness for patients in state hospitals: results from a randomized trial. Psychopharmacol Bull 1996; 32:683-697
10. Rosenheck R, Cramer J, Xu W, Thomas J, Henderson W, Frisman L, Fye C, Charney D: A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. N Engl J Med 1997; 337:809-815
11. Egger M, Zellweger-Zahner T, Schneider M, Junker C, Lengeler C, Antes G: Language bias in randomised controlled trials published in English and German. Lancet 1997; 350:326-329
12. Wahlbeck K, Cheine M, Essali MA: Clozapine vs typical neuroleptic medication for schizophrenia, in The Cochrane Library 1998, issue 4. Oxford, UK, Update Software (http://www.update-software.com/cochrane.htm)
13. Chalmers TC, Celano P, Sacks HS, Smith H Jr: Bias in treatment assignment in controlled clinical trials. N Engl J Med 1983; 309:1358-1361
14. Mulrow CD, Oxman A (eds): Cochrane Collaboration Handbook, in The Cochrane Library, 1997, issue 4. Oxford, UK, Update Software (http://www.update-software.com/ccweb/cochrane/revhb302.htm)
15. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-188
16. Yusuf S, Peto R, Lewis J, Collins R, Sleight P: Beta blockade during and after myocardial infarction: an overview of the randomized trials. Progr Cardiovasc Dis 1985; 17:335-371
17. Lau J, Chalmers TC: Meta-analyst 0.975, 1994 (public domain software available from joseph.lau@es.nemc.org)
18. Altman DG, Bland JM: Detecting skewness from summary information. BMJ 1996; 313:1200
19. Angst J, Jaenicke U, Padrutt A, Scharfetter C: Ergebnisse eines doppelblindversuches von HF 1854 (8-Chlor-11-(4 methyl-1-piperazinyl)-5H-dibeno (b,e) (1,4) diazepine) im Vergleich zu Levomepromazin. Pharmakopsychiatrie, Neuro-Psychopharmakologie 1971; 4:192-200
20. van Praag HM, Korf J, Dols LC: Clozapine versus perphenazine: the value of the biochemical mode of action of neuroleptics in predicting their therapeutic activity. Br J Psychiatry 1976; 129:547-555
21. Bao XG: [A double-blind study on the effect of clozapine, penfluridol, and chlorpromazine in the treatment of schizophrenia] (Chinese). Chung Hua Shen Ching Ching Shen Ko Tsa Chih 1988; 21:274-276
22. Ruiz Ruiz M: Estudio doble ciego comparativo entre clozapina y clorpromacina en las esquizofrenias. Arch Neurobiol (Madrid) 1974; 37:169-180
23. Yang WJ: [Three antipsychotic drugs in the treatment of schizophrenia - a controlled and double-blind study] (Chinese). Chung Hua Shen Ching Ching Shen Ko Tsa Chih 1988; 21:277-280, 318-319
24. Li Y: [Application of NOSIE in the study of neuroleptic treatment] (Chinese). Chung Hua Shen Ching Ching Shen Ko Tsa Chih 1987; 20:325-327
25. Nahunek K, Svestka J, Misurec J, Rodova A: Klinické zkusenosti s clozpinem [Clinical experience with clozapine]. Cesk Psychiatr 1975; 71:11-16
26. Leon CA, Estrada H: Efectos terapeuticos de la clozapina sobre los sintomas de psicosis. Revista Colombiana de Psiquiatria 1974; 3:309-318
27. Gerlach J, Koppelhus P, Helweg E, Monrad A: Clozapine and haloperidol in a single-blind cross-over trial: therapeutic and biochemical aspects in the treatment of schizophrenia. Acta Psychiatr Scand 1974; 50:410-424
28. Fischer-Cornelssen K, Ferner U, Steiner H: Multifokale Psychopharmakaprüfung. Arzneimittelforschung 1974; 24:1006-1007
29. Fischer-Cornelssen KA, Ferner UJ: An example of European multicenter trials: multispectral analysis of clozapine. Psychopharmacol Bull 1976; 12:34-39
30. Fischer-Cornelssen K, Ferner U, Steiner H: Multifokale Psychopharmakaprüfung ("Multihospital Trial"). Arzneimittelforschung 1974; 24:1706-1724
31. Dick P, Rémy M, Rey-Bellet JJ: Essai de comparaison de deux antipsychotiques: la chlorpromazine et la clozapine [Comparison of two antipsychotic drugs: chlorpromazine and clozapine]. Ther Umsch 1975; 32:497-500
32. Ekblom B, Haggstrom JE: Clozapine (Leponex) compared with chlorpromazine: a double-blind evaluation of pharmacological and clinical properties. Curr Ther Res Clin Exp 1974; 16:945-957
33. Niskanen P, Achté K, Jaskari M, Karesoja M, Melsted B, Nilsson LB, Routavaara M, Tamminen T, Tienari P, Vogel G: Results of a comparative double-blind study with clozapine and chlorpromazine in the treatment of schizophrenic patients. Psychiatria Fennica 1974; 307-313
34. Vencovsky E, Peterova E, Baudis P: Srovnáni terapeutického úcinku clozapinu s chlorpromazinem [Comparison of the therapeutic effect of clozapine and chlorpromazine]. Cesk Psychiatr 1975; 71:21-26
35. Honigfeld G, Patin J, Singer J: Clozapine antipsychotic activity in treatment-resistant schizophrenics. Advances in Therapy 1984; 1:77-97
36. Singer K, Law S: Comparative double-blind study with clozapine (Leponex) and chlorpromazine in acute schizophrenia. J Int Med Res 1974; 2:433-435
37. Gerlach J, Thorsen K, Fog R: Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenic patients. Psychopharmacology (Berl) 1975; 40:341-350
38. Chiu E, Burrows G, Stevenson J: Double-blind comparison of clozapine with chlorpromazine in acute schizophrenic illness. Aust NZ J Psychiatry 1976; 10:343-347
39. Ciurezu T, lonescu R, Nica-Udangiu S, Niturad D, Oproiu L, Tudorache D, Popovici I, Curelaru S: Étude clinique en ́double blind́ du HF 1854 (=LX 100-129=clozapine=Leponex) comparé à l'halopéridol. Neurol Psychiatr (Bucur) 1976; 14: 29-34
40. Guirguis E, Voineskos G, Gray J, Schlieman E: Clozapine (Leponex) vs chlorpromazine (Largactil) in acute schizophrenia (a double-blind controlled study). Curr Ther Res 1977; 21: 707-719
41. Itoh H, Miura S, Yagi G, Sakurai S, Ohtsuka N: Some methodological considerations for the clinical evaluation of neuroleptics - comparative effects of clozapine and haloperidol on schizophrenics. Folia Psychiatr Neurol Jpn 1977; 31:17-24
42. Erlandsen C: Utprøving av et nytt nevroleptikum, Leponex (clozapin) hos schizofrene med lang sykehistorie. Nordic J Psychiatry 1981; 35:248-253
43. Shopsin B, Klein H, Aaronsom M, Collora M: Clozapine, chlorpromazine, and placebo in newly hospitalized, acutely schizophrenic patients: a controlled, double-blind comparison. Arch Gen Psychiatry 1979; 36:657-664
44. Klein H, Aronson M, Shopsin B: Clozapine: double-blind controlled trial in the treatment of schizophrenia. Psychopharmacol Bull 1978; 14:12-15
45. Gelenberg AJ, Doller JC: Clozapine versus chlorpromazine for the treatment of schizophrenia: preliminary results from a double-blind study. J Clin Psychiatry 1979; 40:238-240
46. Xu WR, Bao-long Z, Qui C, Mei-fang G: A double-blind study of clozapine and chlorpromazine treatment in the schizophrenics. Chinese J Nervous and Ment Disease 1985; 11: 222-224
47. Claghorn J, Honigfeld G, Abuzzahab FS Sr, Wang R, Steinbook R, Tuason V, Klerman GL: The risks and benefits of clozapine versus chlorpromazine. J Clin Psychopharmacol 1987; 7:377-384
48. Potter WZ, Ko GN, Zhang LD, Van W: Clozapine in China: a review and preview of US/PRC collaboration. Psychopharmacology (Berl) 1989; 99(suppl):S87-S91
49. Klieser E, Schönell H: Klinisch-pharmakologische Studien zur Behandlung schizophrener Minussymptomatik, in Neuere Ansätze zur Diagnostik und Therapie schizophrener Minussymptomatik. Edited by Möller H-J, Pelzer E. Berlin, Springer-Verlag, 1990, pp 217-222
50. Stein D, Schönell H, Klieser E: Haloperidol zur Behandlung des systematisierten Wahns chronisch schizophrener Patienten, in Biologische Psychiatrie 2: Drei-Länder-Symposium für Biologische Psychiatrie. Edited by Saletu B. Stuttgart, Germany, Georg Thieme Verlag, 1989, pp 268-270
51. Liu BL, Chen YY, Yang DS: [Effects of thioridazine on schizophrenics and clinical utility of plasma levels] (Chinese). Chin J Neurol Psychiatry 1994; 27:364-367
52. Klieser E, Strauss WH, Lemmer W: The tolerability and efficacy of the atypical neuroleptic remoxipride compared with clozapine and haloperidol in acute schizophrenia. Acta Psychiatr Scand Suppl 1994; 380:68-73
53. Klieser E, Lehmann E, Heinrich K: Risperidone in comparison with various treatments of schizophrenia, in Serotonin in Antipsychotic Treatment: Mechanisms and Clinical Practice: Medical Psychiatry, vol 3. Edited by Kane JM, Möller H-J, Awouters F. New York, Marcel Dekker, 1996, pp 331-343
54. Lee MA, Thompson PA, Meltzer HY: Effects of clozapine on cognitive function in schizophrenia. J Clin Psychiatry 1994; 55(Sept suppl B):82-87
55. Tamminga CA, Thaker GK, Moran M, Kakigi T, Gao X-M: Clozapine in tardive dyskinesia: observations from human and animal model studies. J Clin Psychiatry 1994; 55(Sept suppl B): 102-106
56. Kane JM, Schooler NR, Marder S, Wirshing W, Ames D, Umbricht D, Safferman A, Baker R, Ganguli R: Efficacy of clozapine versus haloperidol in a long-term clinical trial (abstract). Schizophr Res 1996; 18:127
57. Marder SR, Kane JM, Schooler NR, Wirshing WC, Baker R, Ames D, Umbricht D, Ganguli R, Borenstein M: Effectiveness of clozapine in treatment resistant schizophrenia (abstract). Schizophr Res 1997; 24:187
58. Wirshing WC, Baker R, Umbricht D, Ames D, Schooler N, Kane J, Marder SR, Borenstein D: Clozapine vs haloperidol: drug intolerance in a controlled six month trial (abstract). Schizophr Res 1997; 24:268
59. Kumra S, Frazier JA, Jacobsen LK, McKenna K, Gordon CT, Lenane MC, Hamburger SD, Smith AK, Albus KE, Alaghband-Rad J, Rapoport JL: Childhood-onset schizophrenia: a double-blind clozapine-haloperidol comparison. Arch Gen Psychiatry 1996; 53:1090-1097
60. Hong CJ, Chen JY, Chiu HJ, Sim CB: A double-blind comparative study of clozapine versus chlorpromazine in Chinese patients with treatment-refractory schizophrenia. Int Clin Psychopharmacol 1997; 12:123-130
61. Buchanan BW, Breier A, Kirkpatrick B, Ball P, Carpenter WT Jr: Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome. Am J Psychiatry 1998; 155:751-760
62. Breier A, Buchanan RW, Kirkpatrick B, Davis OR, Irish D, Summerfelt A, Carpenter WT Jr: Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. Am J Psychiatry 1994; 151:20-26
63. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF: Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 1996; 276:637-639
64. Alvir JMJ, Jeffrey PH, Lieberman A, Safferman AZ, Schwimmer JL, Schaaf JA: Clozapine-induced agranulocytosis: incidence and risk factors in the United States. N Engl J Med 1993; 329:162-167
65. Roland M, Torgerson DJ: What are pragmatic trials? BMJ 1998; 316:285